Discover: How Spero Therapeutics Turned a Reduction in Force Into a Loyalty Engine
3:50 pm - Tuesday 8th December 2026
- How can an organization navigate a reduction in force with enough care that former employees choose to come back?
- Discover how Spero Therapeutics handled its RIF with transparency and fairness, kept relationships alive by re-engaging former employees as consultants, and avoided a “two pool” commercial versus R&D culture split that nearly took hold during a failed commercialization push
- Learn how this culture first approach means at least 75% of Spero’s next phase of growth is expected to come from returning employees, proof that how you treat people on the way out shapes whether they come back
